Incor Pharma And Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -139.24%
- Ebitda -344.00%
- Net Worth -1.68%
- Total Assets %
About Incor Pharma And Diagnostics
Incor Pharma And Diagnostics Private Limited (IPADPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 November 2012 and has a history of 12 years and two months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gautham Madduri and Shrihari Pulagam serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110TG2012PTC084319
-
Company No.
084319
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Nov 2012
-
Date of AGM
28 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Incor Pharma And Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gautham Madduri
|
Director | 22-Nov-2012 | Current |
|
Shrihari Pulagam
|
Director | 25-May-2022 | Current |
Financial Performance of Incor Pharma And Diagnostics.
Incor Pharma And Diagnostics Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 139.24% decrease in profit. The company's net worth dipped by a decrease of 1.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Incor Pharma And Diagnostics?
In 2020, Incor Pharma And Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Ingrow Hospitality Private LimitedShrihari Pulagam is a mutual person
-
Incor Lake City Projects Private LimitedShrihari Pulagam is a mutual person
-
Incor Infrastructure Private Limited
Shrihari Pulagam is a mutual person
-
Incor Patancheru Heights Private Limited
Shrihari Pulagam is a mutual person
-
Incor S.P Holdings Private Limited
Shrihari Pulagam is a mutual person
-
Veptor Projects Private Limited
Shrihari Pulagam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Incor Pharma And Diagnostics?
Unlock and access historical data on people associated with Incor Pharma And Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Incor Pharma And Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incor Pharma And Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
